NCT06015035 2023-08-29Sintilimab and Anlotinib Combined With Chemotherapy in Neoadjuvant Treatment of Resectable Esophageal CancerTang-Du HospitalPhase 2 Completed17 enrolled
NCT05303740 2022-03-31Anlotinib Retrospective Study for Esophageal CancerThe First Affiliated Hospital of Zhengzhou UniversityCompleted300 enrolled